Toolkit/LV-EcpG
LV-EcpG
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
we developed a biosensor based on turn-on fluorescent protein, named LV-EcpG
Usefulness & Problems
Why this is useful
LV-EcpG is a genetically encoded turn-on fluorescent protein biosensor for direct visual detection of living endothelial cells. Its fluorescence is reported to switch on upon binding to endothelial cells.; non-invasive detection of living endothelial cells; direct visual detection of endothelial cells; multicolor imaging in live endothelial cell research
Source:
LV-EcpG is a genetically encoded turn-on fluorescent protein biosensor for direct visual detection of living endothelial cells. Its fluorescence is reported to switch on upon binding to endothelial cells.
Source:
non-invasive detection of living endothelial cells
Source:
direct visual detection of endothelial cells
Source:
multicolor imaging in live endothelial cell research
Problem solved
It addresses rapid and convenient endothelial cell detection without immunostaining. The design is intended for non-invasive live-cell readout.; detecting living endothelial cells specifically without immunostaining
Source:
It addresses rapid and convenient endothelial cell detection without immunostaining. The design is intended for non-invasive live-cell readout.
Source:
detecting living endothelial cells specifically without immunostaining
Problem links
detecting living endothelial cells specifically without immunostaining
LiteratureIt addresses rapid and convenient endothelial cell detection without immunostaining. The design is intended for non-invasive live-cell readout.
Source:
It addresses rapid and convenient endothelial cell detection without immunostaining. The design is intended for non-invasive live-cell readout.
Published Workflows
Objective: Engineer a genetically encoded turn-on fluorescent biosensor for rapid, convenient, non-invasive, and specific detection of living endothelial cells without immunostaining.
Why it works: The abstract states that a high-affinity endothelial-recognition peptide was combined with a turn-on EGFP architecture so that fluorescence is activated only upon binding to endothelial cells.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
Selection / EnrichmentTarget processes
No target processes tagged yet.
Implementation Constraints
The biosensor includes the endothelial-recognition peptide E12P and a turn-on EGFP fused with two linker peptides. Use requires live-cell fluorescence imaging.; requires the E12P endothelial-recognition peptide component; requires a turn-on EGFP fused with two linker peptides
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Supporting Sources
Ranked Claims
LV-EcpG enables direct, visual, and non-invasive detection of living endothelial cells without immunostaining.
thus enabling these FPB characters for direct, visual, and non-invasive detection of ECs
LV-EcpG includes the high-affinity peptide E12P and a turn-on EGFP fused with two linker peptides.
It includes a high-affinity peptide E12P obtained through phage display technology for specifically recognizing ECs and a turn-on EGFP fused with two linker peptides.
LV-EcpG uses an on-off switching mechanism in which fluorescence is activated only when the biosensor binds endothelial cells.
The "on-off" switching mechanism of this genetically encoded fluorescent protein-based biosensor (FPB) ensured that fluorescence signals were activated only when binding with ECs
LV-EcpG is reported to have specificity and multicolor imaging capability for live endothelial cell research.
Its specificity and multicolor imaging capability established LV-EcpG as a powerful tool for live EC research
The paper reports development of LV-EcpG, a turn-on fluorescent protein biosensor for endothelial cell detection.
we developed a biosensor based on turn-on fluorescent protein, named LV-EcpG
Approval Evidence
we developed a biosensor based on turn-on fluorescent protein, named LV-EcpG
Source:
LV-EcpG enables direct, visual, and non-invasive detection of living endothelial cells without immunostaining.
thus enabling these FPB characters for direct, visual, and non-invasive detection of ECs
Source:
LV-EcpG includes the high-affinity peptide E12P and a turn-on EGFP fused with two linker peptides.
It includes a high-affinity peptide E12P obtained through phage display technology for specifically recognizing ECs and a turn-on EGFP fused with two linker peptides.
Source:
LV-EcpG uses an on-off switching mechanism in which fluorescence is activated only when the biosensor binds endothelial cells.
The "on-off" switching mechanism of this genetically encoded fluorescent protein-based biosensor (FPB) ensured that fluorescence signals were activated only when binding with ECs
Source:
LV-EcpG is reported to have specificity and multicolor imaging capability for live endothelial cell research.
Its specificity and multicolor imaging capability established LV-EcpG as a powerful tool for live EC research
Source:
The paper reports development of LV-EcpG, a turn-on fluorescent protein biosensor for endothelial cell detection.
we developed a biosensor based on turn-on fluorescent protein, named LV-EcpG
Source:
Comparisons
Source-stated alternatives
The abstract contrasts LV-EcpG with immunostaining by emphasizing detection specifically without immunostaining.
Source:
The abstract contrasts LV-EcpG with immunostaining by emphasizing detection specifically without immunostaining.
Source-backed strengths
fluorescence is activated only when binding with endothelial cells; specificity for endothelial cells is claimed; supports multicolor imaging
Source:
fluorescence is activated only when binding with endothelial cells
Source:
specificity for endothelial cells is claimed
Source:
supports multicolor imaging
Compared with immunostaining
The abstract contrasts LV-EcpG with immunostaining by emphasizing detection specifically without immunostaining.
Shared frame: source-stated alternative in extracted literature
Strengths here: fluorescence is activated only when binding with endothelial cells; specificity for endothelial cells is claimed; supports multicolor imaging.
Source:
The abstract contrasts LV-EcpG with immunostaining by emphasizing detection specifically without immunostaining.
Ranked Citations
- 1.